Including patient voice in therapeutic choices in breast cancer care.

One2Treat patented software was used by both clinicians and breast cancer patients’ representatives in Italy and Portugal, enabling to foster more effective, patient-centered discussions. The software provided personalized benefit-risk assessments directly from clinical trial data, prioritizing the most relevant outcomes to each patient. Facilitating this shared decision-making process is instrumental to improve both treatment acceptance and adherence.